How Sialylated IgG Can Help Fight the Flu

-

Image credit: https://openai.com/index/dall-e/


We all know how miserable the flu can make us feel. While most of us recover without too much trouble, for some people, it can lead to serious complications. Researchers are constantly looking for better ways to understand and combat the flu. This article sheds light on a fascinating discovery about a specific type of antibody that seems to play a crucial role in how our bodies respond to the flu virus.


The role of Sialylated IgG: The study focuses on a type of antibody called immunoglobulin G (IgG). These antibodies are part of the immune system's defense force. What's particularly interesting is that these IgG antibodies can have a specific sugar molecule attached to them, known as sialic acid. When IgG has this sugar, it’s called sialylated IgG. It turns out that this small addition can make a big difference.

The researchers found that people with mild flu infections had higher levels of sialylated IgG in their bodies compared to those who had severe infections. This suggests that sialylated IgG can help protect against severe flu.


How Sialylated IgG works: So, how does sialylated IgG work its magic? It appears that it works by influencing the behavior of certain immune cells in the lungs called alveolar macrophages. These cells are like the first responders in the lungs when an infection occurs.

Sialylated IgG triggers these macrophages to produce a protein called REST (repressor element-1 silencing transcription factor). REST is like a switch that calms down the immune response. It stops the macrophages from overreacting to the virus. This is important because an overactive immune response can actually cause damage to the lungs.

When the macrophages don't overreact, it helps to reduce inflammation and protects the lungs from damage. It appears that the sialylated IgG does not impact virus replication, so the reduced inflammation seems to be the key mechanism by which it works.


Key findings:

  • Mild Flu and Sialylated IgG: People with mild flu had more of the sialylated form of IgG antibodies.
  • Sialylated IgG is Protective: In mice, sialylated IgG helped protect against different flu viruses, reducing lung inflammation.
  • REST is Key: Sialylated IgG activates REST in lung immune cells, helping to control the inflammatory response.
  • Inflammation Control: Sialylated IgG appears to reduce production of inflammatory substances in the lungs.
  • Improved Lung Function: Mice treated with sialylated IgG had better lung function during flu infection, as shown by increased blood oxygen and reduced carbon dioxide.


The impact on Flu Treatment

These findings could be very useful in developing new ways to treat the flu. The study showed that giving mice a specially made, sialylated Fc molecule (a part of the IgG antibody) could activate REST and protect them from severe flu, even when given after they were infected. This could lead to new treatments that don't directly target the virus, but rather help the body manage its response to it.

The interesting thing about this is that because the sialylated IgG appears to work by calming down the immune system, and not by targeting the virus directly, it could work against different types of flu, even as the virus changes over time.


Why some people are more susceptible: It is interesting to note that the body's levels of sialylated IgG changes with age. Younger people tend to have more of it, which may explain why they often experience milder flu compared to older adults. This reduction in sialylated IgG with age might be one reason why the elderly are more vulnerable to severe flu.


What's next: This research offers exciting new possibilities for flu treatment. By understanding how sialylated IgG and REST work together, scientists can develop therapies that can help our bodies better manage the flu and prevent serious complications. It also opens the door for more research into how we might use sialylated IgG to help with other inflammatory conditions.


In summary: This study highlights the role of sialylated IgG in fighting flu. It calms down the body’s response to the virus, preventing dangerous inflammation in the lungs. The next time you hear about flu research, remember that it’s not just about attacking the virus; it's also about helping our bodies respond in the best way possible.

 

Additional information: Sialylated IgG induces the transcription factor REST in alveolar macrophages to protect against lung inflammation and severe influenza disease. Immunity (2025). https://doi.org/10.1016/j.immuni.2024.10.002

Journal information: https://www.cell.com/immunity/home

Location: Oxford, UK

Comments

Post a Comment

Popular posts from this blog

Unlocking insights: simplifying single-cell data with Strand’s scRNA portal

-
Image
Image credit:   https://scrna-curation.mystrand.org/ Simplifying single-cell data exploration with Strand’s scRNA portal In the rapidly advancing world of single-cell RNA sequencing (scRNA-seq), navigating complex datasets can be a major challenge. Strand’s scRNA Portal is designed to transform this challenge into an opportunity by harmonizing publicly available datasets, making disease-specific omics data accessible, actionable, and ready for discovery. Why strand’s scRNA portal was built 1) Focus on unmet needs in key diseases Starting with datasets with diseases with significant unmet clinical need: Inflammatory bowel disease :  Covering Ulcerative Colitis and Crohn’s Disease. Neurodegenerative disorders :  Including Alzheimer’s Disease, Parkinson’s Disease and Frontotemporal Dementia. 2)  The rise of scRNA-seq in aiding precision medicine:  Single-cell RNA sequencing provides unprecedented insights into cellular heterogeneity, which is pivotal for identifyi...
Read more

Understanding Your Immune System: A Lifespan Journey

-
Image
Image credit:   https://openai.com/index/dall-e/   Have you ever wondered how your immune system changes as you get older? It’s not just about catching colds, our immune system is always working hard to protect us and it’s constantly evolving throughout our lives. A new study has looked at how our immune system changes from birth right through to old age, providing some fascinating insights. What the study did : Scientists looked at blood samples from a large group of healthy people, ranging from newborns to those over 90 years old. They used advanced techniques to study the different types of immune cells in these samples. They looked at how these cells behave and change over time. This is called a "single-cell atlas," because they looked at each cell individually. Key findings Immune cells change over time: The study identified 25 different types of immune cells in the blood. The number of each type of cell changes throughout life. Some become more commo...
Read more

Cracking the code of itchy skin: A new way to diagnose and treat skin problems

-
Image
a : The ridgeline plots show the activity scores of different immune response types (Th1, Th2, Th17, type I interferon, neutrophil-related, macrophage-related, and eosinophil-related responses) in skin samples from different inflammatory skin diseases (Psoriasis, Atopic Dermatitis, Lichen Planus, Cutaneous Lupus Erythematosus, Neutrophilic Dermatosis, and Wells Syndrome). The solid lines mark the point where each response type is considered active. b : Box plots compare the immune response scores in skin samples across all these diseases for the "sentinel" (reference) biopsies. Each dot is one sample. The number of samples for each condition is listed: Psoriasis (25), Atopic Dermatitis (16), etc., along with healthy controls (8). c : Box plots show the immune response scores for "test" samples (a different set of biopsies). Sample numbers for each disease are also listed, like Psoriasis (8) and Atopic Dermatitis (15). b–c : In the box plots, the middle line shows th...
Read more